Literature DB >> 10738672

Shigella and Shiga toxin-producing Escherichia coli causing bloody diarrhea in Latin America.

E L López1, V Prado-Jiménez, M O'Ryan-Gallardo, M M Contrini.   

Abstract

In Latin America, Shigella and shiga toxin-producing Escherichia coli are the two leading agents in the cause of bloody diarrhea. The already high and increasing antimicrobial resistance of Shigella also is a significant problem. Shiga toxin-producing E. coli is an emerging disease with life-threatening complications: hemolytic uremic syndrome. Although E. coli O157:H7 remains the most commonly recognized serotype, recently emerging, non-O157 bacteria may be the cause of a similar spectrum of disease in humans.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10738672     DOI: 10.1016/s0891-5520(05)70217-8

Source DB:  PubMed          Journal:  Infect Dis Clin North Am        ISSN: 0891-5520            Impact factor:   5.982


  7 in total

1.  Shiga toxin-producing Escherichia coli infection and antibodies against Stx2 and Stx1 in household contacts of children with enteropathic hemolytic-uremic syndrome.

Authors:  Kerstin Ludwig; Volkan Sarkim; Martin Bitzan; Mohamed A Karmali; Christoph Bobrowski; Hans Ruder; Rainer Laufs; Ingo Sobottka; Martin Petric; Helge Karch; Dirk E Müller-Wiefel
Journal:  J Clin Microbiol       Date:  2002-05       Impact factor: 5.948

2.  Antibody response to Shiga toxins Stx2 and Stx1 in children with enteropathic hemolytic-uremic syndrome.

Authors:  K Ludwig; M A Karmali; V Sarkim; C Bobrowski; M Petric; H Karch; D E Müller-Wiefel
Journal:  J Clin Microbiol       Date:  2001-06       Impact factor: 5.948

3.  A DNA vaccine encoding the enterohemorragic Escherichia coli Shiga-like toxin 2 A2 and B subunits confers protective immunity to Shiga toxin challenge in the murine model.

Authors:  Leticia V Bentancor; Marcos Bilen; Romina J Fernández Brando; María Victoria Ramos; Luis C S Ferreira; Pablo D Ghiringhelli; Marina S Palermo
Journal:  Clin Vaccine Immunol       Date:  2009-01-28

4.  Age and manifestation related symptoms in familial adenomatous polyposis.

Authors:  Roland S Croner; Wolfgang M Brueckl; Bertram Reingruber; Werner Hohenberger; Klaus Guenther
Journal:  BMC Cancer       Date:  2005-03-02       Impact factor: 4.430

5.  Laboratory-based surveillance of Shigella spp. from human clinical cases in Colombia, 1997-2018

Authors:  Edna Catering Rodríguez; Adriana Marcela Bautista; Lucy Angeline Montaño; María Victoria Ovalle; Francia Patricia Correa
Journal:  Biomedica       Date:  2021-03-19       Impact factor: 0.935

6.  Functional capacity of Shiga-toxin promoter sequences in eukaryotic cells.

Authors:  Leticia V Bentancor; Marcos F Bilen; María P Mejías; Romina J Fernández-Brando; Cecilia A Panek; Maria V Ramos; Gabriela C Fernández; Martín Isturiz; Pablo D Ghiringhelli; Marina S Palermo
Journal:  PLoS One       Date:  2013-02-22       Impact factor: 3.240

7.  A recombinant O-polysaccharide-protein conjugate approach to develop highly specific monoclonal antibodies to Shiga toxin-producing Escherichia coli O157 and O145 serogroups.

Authors:  Daniela S Castillo; Diego A Rey Serantes; Luciano J Melli; Andrés E Ciocchini; Juan E Ugalde; Diego J Comerci; Alejandro Cassola
Journal:  PLoS One       Date:  2017-10-05       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.